Lupin receives USD 25 million from AbbVie for successful initiation of Phase 1 clinical studies EP News Bureau Jun 30, 2023 Lupin and AbbVie inked the licensing, development, and commercialisation agreement in 2018 for this novel oncology drug to treat…
Moderna Phase 1 results show coronavirus vaccine safe, induces immune response Reuters Jul 16, 2020 Volunteers who got two doses of the vaccine had high levels of virus-killing antibodies that exceeded the average levels seen in…
